ADRA1B rs10515807: What Your Genotype Means
The rs10515807 variant is a genetic change located within the ADRA1B gene, which provides instructions for creating a specific type of adrenergic receptor. Research suggests this variant may be associated with differences in how individuals respond to certain therapeutic interventions, specifically regarding medication dosage requirements.
What each genotype means
Reduced therapeutic dosage risk
This genotype is associated with a reduced risk of requiring higher dosage steps for certain therapeutic interventions. Because the evidence for this association is currently limited, you should discuss any medication dosing or treatment plans with your clinician or pharmacist.
This is a common genotype found across many global populations.
Typical therapeutic dosage profile
Carriers of this genotype possess one copy of the G allele associated with reduced dosage requirements and one copy of the A allele. The clinical significance of this heterozygous state is not fully established, so please consult your healthcare provider regarding any medication management.
This is a common genotype found across many global populations.
Standard therapeutic dosage profile
This genotype represents the absence of the G allele associated with reduced dosage requirements. As with any genetic profile, this does not dictate your clinical response, and you should discuss all medication dosing with your clinician or pharmacist.
This is a common genotype found across many global populations.
Understanding the rs10515807 Variant
The rs10515807 variant is a single nucleotide polymorphism (SNP) located within the ADRA1B gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is situated in an intronic region of the gene, meaning it lies within a non-coding sequence that is removed during the process of creating a functional protein. While intronic variants do not change the protein's amino acid sequence directly, they can influence how a gene is regulated, expressed, or spliced. Scientists study these variations to understand how subtle differences in our genetic code might contribute to biological diversity and individual differences in health outcomes or responses to environmental factors, including medications.
The Role of the ADRA1B Gene
The ADRA1B gene encodes the alpha-1B adrenergic receptor, a protein that belongs to the G protein-coupled receptor family. These receptors are found on the surface of cells and play a critical role in the body's sympathetic nervous system, which manages the 'fight-or-flight' response. By binding to signaling molecules like adrenaline and noradrenaline, these receptors help regulate various physiological processes, including the constriction of blood vessels and the maintenance of blood pressure. Because of their central role in cardiovascular function, the ADRA1B receptor is a target for several classes of medications. Understanding how genetic variations in this gene might alter receptor function or expression levels is an active area of research, particularly in the field of pharmacogenomics, which examines how genes influence drug response.
Research and Clinical Associations
Current research into rs10515807 has explored its potential link to therapeutic outcomes, specifically regarding the dosage of alpha-adrenergic receptor blockers. Some studies have observed that individuals carrying certain alleles of this variant may require different dosage steps to achieve the desired therapeutic effect compared to those with other genotypes. However, the evidence supporting these associations is currently considered limited. While some findings suggest a correlation between the variant and drug response, these results are often based on specific study populations and have not been universally replicated across all ethnic or clinical groups. Because the evidence is not yet robust enough to guide standard clinical practice, this information should be viewed as an area of ongoing scientific investigation rather than a definitive predictor of how any single person will respond to a medication.
Population Frequency and Interpretation
The rs10515807 variant is classified as a common polymorphism, meaning that the different alleles are found at significant frequencies across various human populations. Because it is common, many people carry one or more copies of the variant alleles. It is important to remember that having a specific genotype for this SNP does not mean an individual will experience a specific health outcome or drug response. Genetic associations are statistical in nature, describing trends observed in large groups of people rather than predicting the future of an individual. If you are concerned about how a medication might affect you, or if you are curious about your own genetic profile, it is essential to discuss these topics with a qualified healthcare provider or a clinical pharmacist who can interpret your health history in the context of your overall genetic and clinical background.
How common is this variant?
The rs10515807 variant is a common polymorphism, with both the A and G alleles appearing at significant frequencies across diverse global populations.
Frequently asked questions
Can I use this genetic information to change my medication dosage?
No. You should never change your medication dosage based on genetic information without consulting your doctor. Genetic associations are statistical trends and do not account for all the factors that influence how a drug works in your body.
Is rs10515807 a diagnostic test for a disease?
No, rs10515807 is not a diagnostic test. It is a genetic variant studied for its potential influence on drug response, and it is not used to diagnose any specific medical condition.
Where can I find more information about my specific genotype?
If you have received genetic testing results, you should discuss them with a genetic counselor or your primary care physician. They can help you understand the clinical relevance of your results in the context of your personal health.
Why is the evidence for this variant considered limited?
Evidence is considered limited when studies are small, have not been replicated in diverse populations, or show inconsistent results. More research is needed to confirm the clinical significance of this variant.
Sources & further reading
Educational information only, last refreshed 9/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10515807?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29